ANAB
AnaptysBio Inc

2,042
Mkt Cap
$1.52B
Volume
275,877.00
52W High
$57.74
52W Low
$13.99
PE Ratio
-19.53
ANAB Fundamentals
Price
$55.05
Prev Close
$56.11
Open
$55.84
50D MA
$49.46
Beta
0.73
Avg. Volume
488,548.55
EPS (Annual)
-$5.12
P/B
-51.60
Rev/Employee
$671,176.47
$359.87
Loading...
Loading...
News
all
press releases
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis Vanda Pharmaceuticals Announces FDA...
PR Newswire·5d ago
News Placeholder
More News
News Placeholder
AnaptysBio (NASDAQ:ANAB) Reaches New 1-Year High - Time to Buy?
AnaptysBio (NASDAQ:ANAB) Sets New 12-Month High - Still a Buy...
MarketBeat·5d ago
News Placeholder
Skandinaviska Enskilda Banken AB publ Has $4.45 Million Stock Position in AnaptysBio, Inc. $ANAB
Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 333.1% in the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·9d ago
News Placeholder
AnaptysBio, Inc. $ANAB Stock Holdings Trimmed by GSA Capital Partners LLP
GSA Capital Partners LLP lowered its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 46.6% during the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·11d ago
News Placeholder
AnaptysBio (ANAB) to Release Quarterly Earnings on Thursday
AnaptysBio (NASDAQ:ANAB) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·11d ago
News Placeholder
Insider Selling: AnaptysBio (NASDAQ:ANAB) Insider Sells 10,000 Shares of Stock
AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) insider Eric Loumeau sold 10,000 shares of AnaptysBio stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Insider Sells $540,000.00 in Stock
AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) insider Eric Loumeau sold 10,000 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $54.00...
MarketBeat·16d ago
News Placeholder
AnaptysBio Details Q2 Royalty Spin, Jemperli Growth and ANB033 Celiac Data Coming in Q4
AnaptysBio (NASDAQ:ANAB) leadership outlined plans to separate its royalty business from its clinical-stage biopharma operations, while also discussing key revenue drivers tied to GSK's Jemperli...
MarketBeat·17d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Sets New 52-Week High - Should You Buy?
AnaptysBio (NASDAQ:ANAB) Sets New 1-Year High - Time to Buy...
MarketBeat·18d ago
News Placeholder
AnaptysBio Teases Q2 Split Into RoyaltyCo and Biopharma Spin, Flags Jemperli and Pipeline Catalysts
AnaptysBio (NASDAQ:ANAB) outlined plans to separate its business into two publicly traded entities and reviewed upcoming clinical and commercial catalysts during a discussion at the Guggenheim...
MarketBeat·18d ago
<
1
2
...
>

Latest ANAB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.